Back

Multidrug therapy with terbinafine plus daily fluconazole is more effective than terbinafine alone or terbinafine plus weekly fluconazole in current epidemic of altered dermatophytosis in India: Results of a randomized pragmatic trial

Singh, S.; Jha, B.; Shukla, P.; Anchan, V. N.

2019-08-22 dermatology
10.1101/19005025 medRxiv
Show abstract

BackgroundTreatment responsiveness of tinea has decreased considerably in recent past in India. We tested effectiveness of oral terbinafine daily plus fluconazole weekly (TFw) and terbinafine daily plus fluconazole daily (TFd) versus oral terbinafine daily (T) in tinea corporis, tinea cruris and tinea faciei in a pragmatic randomized open trial. MethodsOne hundred and seventeen microscopy confirmed patients were allocated to T (6 mg/kg/day), TFw (terbinafine 6 mg/kg/day+fluconazole 12 mg/kg once weekly), or TFd (terbinafine 6 mg/kg/day+fluconazole 6 mg/kg/day) groups by concealed randomization and treated for 8 weeks or cure. Each group included 39 patients. ResultsAt 4 weeks, 9 (23.1%), 8 (20.5%) and 14 (35.9%) patients were cured in T, TFw and TFd groups, respectively (P=0.279). At 8 weeks, number of patients cured was as follows: T 13 (33.3%), TFw 18 (46.2%) and TFd 25 (64.1%). TFd was more effective than T (P=0.012), other comparisons were not significantly different. However, effect size as calculated by number needed to treat (NNT) (versus terbinafine) was 8 for TFw and 4 for TFd. Relapse rates one month after cure were similar in all groups (P=0.664). ConclusionsIn view of cure rates and NNT, terbinafine plus daily fluconazole is more effective than terbinafine alone or terbinafine plus weekly fluconazole in current epidemic of altered dermatophytosis in India. One Sentence SummaryTerbinafine plus daily fluconazole is more effective than terbinafine alone or terbinafine plus weekly fluconazole in current epidemic of altered dermatophytosis in India.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS Neglected Tropical Diseases
378 papers in training set
Top 0.3%
27.3%
2
PLOS ONE
4510 papers in training set
Top 24%
7.2%
3
Cureus
67 papers in training set
Top 0.4%
7.2%
4
PLOS Medicine
98 papers in training set
Top 0.4%
6.7%
5
eClinicalMedicine
55 papers in training set
Top 0.1%
6.7%
50% of probability mass above
6
JAMA Network Open
127 papers in training set
Top 0.6%
4.5%
7
Frontiers in Medicine
113 papers in training set
Top 2%
3.2%
8
Blood Advances
54 papers in training set
Top 0.5%
3.2%
9
Scientific Reports
3102 papers in training set
Top 46%
2.5%
10
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 2%
2.2%
11
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.9%
2.0%
12
Frontiers in Public Health
140 papers in training set
Top 4%
1.8%
13
The Lancet Microbe
43 papers in training set
Top 0.8%
1.3%
14
Experimental Dermatology
10 papers in training set
Top 0.2%
1.0%
15
Nature Communications
4913 papers in training set
Top 58%
0.9%
16
BMC Cancer
52 papers in training set
Top 2%
0.8%
17
Trials
25 papers in training set
Top 2%
0.8%
18
European Respiratory Journal
54 papers in training set
Top 2%
0.7%
19
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.7%
0.7%
20
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.5%
21
Frontiers in Nutrition
23 papers in training set
Top 2%
0.5%
22
Frontiers in Immunology
586 papers in training set
Top 9%
0.5%
23
Clinical Microbiology and Infection
60 papers in training set
Top 2%
0.5%
24
Journal of Infection
71 papers in training set
Top 4%
0.5%